CONSTANT LEVERAGE SHORT - UCB Stock

Z5YFB

NLBNPNL1Q9M6

Real-time Euronext Paris 10:18:57 2024-06-03 EDT
1.495 ^EUR	-2.61%

1 month	-9.71%
3 months	-47.79%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB : Acquisition of own shares	05-31	PU
UCB : Commitment to Innovation in Drug Development	05-29	PU
UCB : announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa	05-23	PU
UCB - Acquisition of own shares	05-20	AQ

More news

Quotes 5-day view

Date	Price	Change
24-06-03	1.495	-2.61%
24-05-31	1.535	-3.76%
24-05-30	1.595	+1.92%
24-05-29	1.565	0.00%
24-05-28	1.565	+2.62%

Real-time Euronext Paris

Last update June 03, 2024 at 10:18 am

More quotes

Static data

Product type	Produits Exotiques
Buy / Sell	PUT
Underlying	UCB
Issuer	BNP Paribas
	Z5YFB
ISIN	NLBNPNL1Q9M6
Date issued	2022-03-09
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	19.54 €
Lowest since issue	1.465 €
Spread	0.01 €
Spread %	0.66%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

128.6 EUR

Average target price

126.4 EUR

Spread / Average Target

-1.76%

Consensus